Showing 251-260 of 1329 results for "".
Neuromyelitis Optica Spectrum Disorder in Castleman Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuromyelitis-optica-spectrum-disorder-in-castleman-disease/32104/A novel case report involving two rare clinical entities.Stroke in a Young Adult:
Immunomodulation-Responsive Bilateral Supraclinoid Carotid Artery Vasculopathy Secondary to Systemic Lupus Erythematosushttps://practicalneurology.com/diseases-diagnoses/stroke/stroke-in-a-young-adultbrimmunomodulation-responsive-bilateral-supraclinoid-carotid-artery-vasculopathy-secondary-to-systemic-lupus-erythematosus/32069/A rare case of ischemic stroke in the setting of large-vessel vasculopathy in an individual with systemic lupus erythematosus.Frontotemporal Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/frontotemporal-dementias/31537/Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.Neurology Clinical Trials in the Community Hospital Setting
https://practicalneurology.com/columns/practice-management/neurology-clinical-trials-in-the-community-hospital-setting/30850/A significant trend, encouraged by NIH, is expanding clinical research to community hospitals with potential benefits for patients and clinicians.- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31423/In July 2005, Practical Neurology highlighted the controversial remarks made by actor Tom Cruise regarding the field of psychiatry, reflecting broader implications for mental health advocacy and public perception. Cruise’s outspoken criticism emerged shortly after a public dispute with Brooke Shield
Video-Case Report: Progressive Neuropathy With Cerebellar Ataxia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/video-case-report-progressive-neuropathy-with-cerebellar-ataxia/30169/Investigation of antibody titers is essential for patients who have neuropathy with cerebellar ataxia and do not respond to IVIG treatment.Prognostic Factors in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/prognostic-factors-in-multiple-sclerosis/31874/Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time.Neuromuscular & Autonomic Complications of COVID-19
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-autonomic-complications-of-covid-19/31810/Potential causal relationships can be assessed by criteria of strength, consistency, temporality, biologic gradient, plausibility, coherence, and analogy.Posttraumatic Headache: A Comprehensive Approach
https://practicalneurology.com/diseases-diagnoses/headache-pain/posttraumatic-headache-a-comprehensive-approach/32130/A multimodal, comprehensive, individualized approach to the treatment of posttraumatic headache is essential to optimize outcomes.